Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: A systematic review and meta-analysis

Journal of Gastrointestinal Oncology

Volumn 5, Issue 2, 2014, Pages 119-126

  Nagaraja, Vinayak ^a   Cox, Michael R ^a   Eslick, Guy D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Esophageal cancer; Neoadjuvant therapy; Self expandable metal stents

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CANCER ADJUVANT THERAPY; DYSPHAGIA; ESOPHAGEAL STENT; ESOPHAGUS CANCER; HUMAN; MEDICAL DEVICE COMPLICATION; META ANALYSIS; OUTCOMES RESEARCH; PATIENT SAFETY; SCORING SYSTEM; SELF EXPANDING STENT; STENT MIGRATION; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 84995801947     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2014.007     Document Type: Article

References (51)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-55.
3. Thompson SK, Ruszkiewicz AR, Jamieson GG, et al. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 2008;15:3447-58.
4. Larrea J, Vega S, Martinez T, et al. The nutritional status and immunological situation of cancer patients. Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral 1992;7:178-84.
5. Han-Geurts IJ, Hop WC, Tran TC, et al. Nutritional status as a risk factor in esophageal surgery. Dig Surg 2006;23:159-63.
6. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
7. Jatoi A, Martenson JA, Foster NR, et al. Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol 2007;30:507-13.
8. Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221:327-38.
9. Windsor A, Braga M, Martindale R, et al. Fit for surgery: an expert panel review on optmising patients prior to surgery, with a particular focus on nutrition. The surgeon: journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2004;2:315-9.
10. Gibbs J, Cull W, Henderson W, et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36-42.
11. O'Gorman RB, Feliciano DV, Matthews KS, et al. Correlation of immunologic and nutritional status with infectious complications after major abdominal trauma. Surgery 1986;99:549-56.
12. Reynolds JV, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2006;132:549-55.
13. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-43.
14. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Journal of clinical epidemiology 2009;62:1006-12.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
17. Egger M, Smith GD, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-34.
18. Orwin R. A fail-safe N for effect size in meta-analysis. Journal of educational statistics 1983;8:157-9.
19. Siddiqui AA, Glynn C, Loren D, et al. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus 2009;22:216-22.
20. Adler DG, Fang J, Wong R, et al. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 2009;70:614-9.
21. Siddiqui AA, Loren D, Dudnick R, et al. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci 2007;52:823-9.
22. Bower M, Jones W, Vessels B, et al. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol 2009;16:3161-8.
23. Langer FB, Schoppmann SF, Prager G, et al. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 2010;17:470-5.
24. Pellen MG, Sabri S, Razack A, et al. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer. Dis Esophagus 2012;25:48-53.
25. Siddiqui AA, Sarkar A, Beltz S, et al. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc 2012;76:44-51.
26. Lopes TL, Eloubeidi MA. A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer. Dis Esophagus 2010;23:309-15.
27. Martin R, Duvall R, Ellis S, et al. The use of selfexpanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care. Surgical endoscopy 2009;23:615-21.
28. Siersema PD, van Hillegersberg R. Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Current Opinion in Gastroenterology 2008;24:535-40.
29. Koshy M, Esiashvilli N, Landry JC, et al. Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 2004;9:147-59.
30. Walsh TN, Grennell M, Mansoor S, et al. Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. Diseases of the Esophagus 2002;15:121-4.
31. Di Fiore F, Lecleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-63.
32. Braga M, Gianotti L, Gentilini O, et al. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Critical care medicine 2001;29:242-8.
33. Heys SD, Walker LG, Smith I, et al. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999;229:467-77.
34. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg 1996;224:531-40; discussion 40-3.
35. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992;216:172-83.
36. Bozzetti F, Braga M, Gianotti L, et al. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet 2001;358:1487-92.
37. Jenkinson AD, Lim J, Agrawal N, et al. Laparoscopic feeding jejunostomy in esophagogastric cancer. Surg Endosc 2007;21:299-302.
38. Margolis M, Alexander P, Trachiotis GD, et al. Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 2003;76:1694-7; discussion 7-8.
39. Ohnmacht GA, Allen MS, Cassivi SD, et al. Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus 2006;19:311-2.
40. Date RS, Clements WD, Gilliland R. Feeding jejunostomy: is there enough evidence to justify its routine use? Dig Surg 2004;21:142-5.
41. Han-Geurts IJM, Hop WC, Verhoef C, et al. Randomized clinical trial comparing feeding jejunostomy with nasoduodenal tube placement in patients undergoing oesophagectomy. British Journal of Surgery 2007;94:31-5.
42. O'Donnell CA, Fullarton GM, Watt E, et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. The British journal of surgery 2002;89:985-92.
43. Shenfine J, McNamee P, Steen N, et al. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005;9:iii, 1-121.
44. Bergquist H, Wenger U, Johnsson E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005;18:131-9.
45. Madhusudhan C, Saluja SS, Pal S, et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus 2009;22:331-6.
46. Thompson AM, Rapson T, Gilbert FJ, et al. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a populationbased cohort of 948 patients. Surg Endosc 2004;18:1257-62.
47. Karbowski M, Schembre D, Kozarek R, et al. Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surgical endoscopy 2008;22:1326-33.
48. Costamagna G, Shah SK, Tringali A, et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surgical endoscopy 2003;17:891-5.
49. Holm AN, de la Mora Levy JG, Gostout CJ, et al. Selfexpanding plastic stents in treatment of benign esophageal conditions. Gastrointestinal endoscopy 2008;67:20-5.
50. van Boeckel PG, Sijbring A, Vleggaar FP, et al. Systematic review: temporary stent placement for benign rupture or anastomotic leak of the oesophagus. Alimentary pharmacology & therapeutics 2011;33:1292-301.
51. Martin RC, Woodall C, Duvall R, et al. The use of selfexpanding silicone stents in esophagectomy strictures: less cost and more efficiency. Ann Thorac Surg 2008;86:436-40.